FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Blanks Robert
2. Date of Event Requiring Statement (MM/DD/YYYY)
6/9/2020 

3. Issuer Name and Ticker or Trading Symbol

ARDELYX, INC. [ARDX]
(Last)        (First)        (Middle)

C/O ARDELYX, INC. 34175 ARDENWOOD BLVD
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
See Remarks /
(Street)

FREMONT, CA 94555      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 115395 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)  (2)7/18/2023 Common Stock 33333 $3.42 D  
Stock Option (Right to Buy)  (2)1/6/2025 Common Stock 7657 $23.02 D  
Stock Option (Right to Buy)  (2)1/15/2026 Common Stock 30810 $10.55 D  
Stock Option (Right to Buy)  (3)1/19/2027 Common Stock 63628 $13.90 D  
Stock Option (Right to Buy)  (2)8/9/2027 Common Stock 19884 $4.70 D  
Stock Option (Right to Buy)  (4)1/16/2028 Common Stock 87828 $7.10 D  
Stock Option (Right to Buy)  (5)7/26/2028 Common Stock 54730 $4.30 D  
Stock Option (Right to Buy)  (6)1/17/2029 Common Stock 80000 $2.32 D  
Stock Option (Right to Buy)  (7)1/9/2030 Common Stock 139365 $7.60 D  

Explanation of Responses:
(1) Includes 100,000 restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
(2) The option is fully vested and exercisable.
(3) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 19, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
(4) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
(5) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of July 26, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
(6) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 17, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
(7) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 9, 2020, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Remarks:
Chief Regulatory and Quality Affairs Officer

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Blanks Robert
C/O ARDELYX, INC. 34175 ARDENWOOD BLVD
FREMONT, CA 94555


See Remarks

Signatures
/s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks6/22/2020
**Signature of Reporting PersonDate

Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Ardelyx Charts.
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Ardelyx Charts.